IIM
HCAT icon

INTECH Investment Management’s Health Catalyst HCAT Stock Holding History

INTECH Investment Management’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$19.8K Sell
15,559
-14,501
-48% -$27.3K ﹤0.01% 2066
2025
Q4 		$71.8K Sell
30,060
-6,738
-18% -$18.4K ﹤0.01% 2218
2025
Q3 		$105K Sell
36,798
-5,212
-12% -$17.8K ﹤0.01% 2245
2025
Q2 		$158K Sell
42,010
-3,575
-8% -$14.1K ﹤0.01% 2169
2025
Q1 		$207K Buy
45,585
+17,199
+61% +$91K ﹤0.01% 2079
2024
Q4 		$201K Buy
28,386
+10,611
+60% +$84.5K ﹤0.01% 2030
2024
Q3 		$145K Buy
+17,775
New +$128K ﹤0.01% 1816

Other funds holding HCAT

FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
CF
CDC Financial Chicago, Illinois $157M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WCA
Whetstone Capital Advisors Shawnee Mission, Kansas $288M AUM 44.06% 1-Year Est. Return
PVM
Palogic Value Management Dallas, Texas $237M AUM 5.37% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

INTECH Investment Management's HCAT Position: Q1 2026 in Review

INTECH Investment Management reduced its Health Catalyst (HCAT) stake by 48% in Q1 2026, selling an estimated $27.3K and leaving 15,559 shares worth $19.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2066.

INTECH Investment Management first reported a position in HCAT in Q3 2024 and has held it in 7 quarters since. The position peaked at $207K in Q1 2025. 130 funds tracked by Wall St. Rank hold HCAT as of Q1 2026.

  • INTECH Investment Management held 15,559 shares of Health Catalyst worth $19.8K as of Q1 2026.
  • INTECH Investment Management sold 14,501 Health Catalyst shares in Q1 2026, an estimated $27.3K.
  • Health Catalyst made up ﹤0.01% of INTECH Investment Management's portfolio in Q1 2026, its #2066 holding.
  • INTECH Investment Management first reported a position in Health Catalyst in Q3 2024 and has held it in 7 quarters since.
  • INTECH Investment Management's Health Catalyst position peaked at $207K in Q1 2025.
  • 130 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2026.

Based on INTECH Investment Management's 13F filing for Q1 2026, filed 8 May 2026.